David Green

David A. Green worked at Kroll LLC (Illinois) from 2003 to 2006, serving as Managing Director-Investment Banking in 2006.
From 2006 to 2008, worked at Specialized Health Products International, Inc. as Chief Financial Officer, Treasurer & VP in 2008.
From 2008 to 2010, worked at H2O America as Chief Financial Officer & Treasurer.
Worked at Q Therapeutics, Inc. as Chief Financial Officer from 2015 to 2016.
From 2016 to 2017, worked at Intarcia Therapeutics, Inc. as Chief Accounting Officer.
From 2017 to 2021, worked at Aytu Biopharma, Inc. as Chief Financial Officer, Secretary & Treasurer, and continued as Chief Financial Officer there from 2021 to 2022.
From 2021 to 2024, worked as Chief Financial Officer at Blackswan Vascular, Inc. and Lamamed Solutions, Inc. Also worked as Chief Financial Officer at Prolacta Bioscience, Inc. from 2021 to 2022 and as Chief Financial Officer & Treasurer at Seastar Medical Holding Corp.
from 2024 to 2025.
Held positions at Ernst & Young LLP as Member-Center for Strategic Transactions, and as Chief Financial Officer at Catheter Connections, Inc., San Jose Water Co., H2O America Land Co., The Texas Water Co., and.
Texas Water Alliance Ltd. Education includes an MBA from Rochester Christian University and an undergraduate degree from The State University of New York.